Withdrawal of life support, altruistic suicide, fratricidal killing and euthanasia by lymphocytes: Different forms of drug-induced hepatic apoptosis

Journal of Hepatology

Volumn 31, Issue 4, 1999, Pages 760-770

  Pessayre, Dominique ^a,b   Haouzi, Delphine ^a   Fau, Daniel ^a   Robin, Marie Anne ^a   Mansouri, Abdellah ^a   Berson, Alain ^a  

^a BEAUJON HOSPITAL   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ALKYLATING AGENT; BILE ACID; BLEOMYCIN; CASPASE; COPPER; CYTOCHROME P450; FAS LIGAND; GRANZYME B; TUMOR NECROSIS FACTOR ALPHA; VALPROIC ACID;

ALCOHOLISM; APOPTOSIS; CYTOTOXIC T LYMPHOCYTE; DNA DAMAGE; DRUG INDUCED DISEASE; ENZYME ACTIVATION; HUMAN; LIVER HYPERPLASIA; LIVER TOXICITY; LYMPHOCYTE; MEMBRANE RUPTURE; METABOLITE; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW;

EID: 0032878643     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80360-2     Document Type: Review

References (70)

1. Pessayre D.,Feldmann G.,Haouzi D.,Fau D.,Moreau A. and Neuman M.,Hepatocyte apoptosis triggered by natural substances (cytokines, other endogenous substances and foreign toxins),Cameron RG.,Feuer G., eds.,Apoptosis and its Modulation by Drugs. Handbook of Experimental Pharmacology, Springer Verlag, Heidelberg,in press.
2. Pessayre D.,Fromenty B.,and Mansouri A., Drug-induced steatosis and steatohepatitis, Lemasters JJ., Niemenen AL, eds., Mitochondria in Pathogenesis, New York Plenum Press, in press.
3. White E. Life, death and the pursuit of apoptosis. Genes Develop. 10:1996;1-15.
4. Green DR, Kroemer G. The central executioners of apoptosis: caspases or mitochondria? Trends Cell Biol. 8:1998;267-271.
5. Motoyama S, Kitamura M, Saito S, Minamiya Y, Suzuki H, Saito R, et al. Bcl-2 is located predominantly in the inner membrane and crista of mitochondria in rat liver. Biochem Biophys Res Commun. 249:1998;628-636.
6. Lacronique V, Mignon A, Fabre B, Viollet B, Rouquet N, Molina T, et al. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat Med. 2:1996;80-86.
7. Saito H, Ebinuma H, Takahashi M, Kaneko F, Wakabayashi K, Nakamura M, et al. Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial bcl-2 expression. Hepatology. 27:1998;1233-1240.
8. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun. 244:1998;683-690.
9. Yamamoto M, Fukuda K, Miura N, Suzuki R, Kido T, Komatsu Y. Inhibition by dexamethasone of transforming growth factor β1-induced apoptosis in rat hepatoma cells: a possible association with bcl-XL induction. Hepatology. 27:1998;959-966.
10. Tzung SP, Fausto N, Hockenbery DM. Expression of bcl-2 family during liver regeneration and identification of bcl-X as a delayed response gene. Am J Pathol. 150:1997;1985-1995.
11. Li H, Zhu H, Xu C, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 94:1998;491-501.
12. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell. 94:1998;481-490.
13. Marzo I, Brenner C, Zamzami N, Jürgensmeier JM, Susin SA, Vieira HLA, et al. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 281:1998;2027-2031.
14. Woodfield K, Rück A, Brdiczka D, Halestrap AP. Direct demonstation of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition. Biochem J. 336:1998;287-290.
15. Hüser J, Rechenmacher CE, Blatter LA. Imaging the permeability pore transition in single mitochondria. Biophys J. 74:1998;2129-2137.
16. Green DR, Reed JC. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
17. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snomw BE, Brothers GM, et al. Molecular charaterization of mitochondrial apoptosis-inducing factor. Nature. 397:1999;441-446.
18. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316.
19. Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature. 391:1998;96-99.
20. Leist M, Single B, Castoldi AF, Kühnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med. 185:1997;1481-1486.
21. Gores GJ, Herman B, Lemasters JJ. Plasma membrane bleb formation and rupture: a common cause of hepatocellular injury. Hepatology. 11:1990;690-698.
22. Patel T, Gores GJ. Apoptosis and hepatobiliary disease. Hepatology. 21:1995;1725-1741.
23. Schulte-Hermann R, Bursch W, Grasl-Kraupp B. Active cell death (apoptosis) in liver biology and disease. Progress Liver Dis. 13:1995;1-35.
24. Pessayre D. Role of reactive metabolites in drug-induced hepatitis. J Hepatol. 23:1995;S16-S24.
25. Gonzales FJ, Nebert DW. Evolution of the cytochrome P-450 gene superfamily: animal-plant"warfare", molecular drive and human genetic differences in drug oxidation. Trends Genet. 6:1990;182-186.
26. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of the Fas ligand in the development of hepatitis. Nat Med. 3:1997;409-413.
27. Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, et al. Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol. 158:1997;5283-5291.
28. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365.
29. Darmon AJ, Nicholson DW, Bleakley RC. Activation of the apoptosis protease CPP32 by cytosolic T-cell-derived granzyme B. Nature. 377:1995;446-448.
30. Bellomo G, Orrenius S. Altered thiol and calcium homeostasis in oxidative hepatocellular injury. Hepatology. 5:1985;876-882.
31. 2+ antagonists inhibit DNA fragmentation and toxic cell death induced by acetaminophen. FASEB J. 7:1993;453-463.
32. Kamendulis LM, Corcoran GB. DNA as a critical target in toxic cell death: enhancement of dimethylnitrosamine cytotoxicity by DNA repair inhibitors. J Pharmacol Exp Ther. 271:1994;1694-1698.
33. Cascales M, Alvarez A, Gasco P, Fernandez-Simon L, Sanz N, Bosca L. Cocaine-induced liver injury in mice exhibits specific changes in DNA ploidy and induces programmed death of hepatocytes. Hepatology. 20:1994;992-1001.
34. Fau D, Lekehal M, Farrell G, Moreau A, Moulis C, Feldmann G, et al. Diterpenoids from germander, a herbal medicine, induce apoptosis in isolated rat hepatocytes. Gastroenterology. 113:1997;1334-1346.
35. Shi J, Aisaki K, Ikawa Y, Wake K. Evidence of hepatocyte apoptosis in rat liver after the administration of carbon tetrachloride. Am J Pathol. 153:1998;515-525.
36. Oyaizu T, Shikata N, Senzaki H, Matsuzawa A, Tsubura A. Studies on the mechanism of dimethylnitrosamine-induced liver injury in mice. Exp Mol Pathol. 49:1997;375-380.
37. Larrey D, Vial T, Pauwels A, Castot A, Biour M, David M, et al. Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med. 117:1992;129-132.
38. Loeper J, Descatoire V, Lettéron P, Moulis C, Degott C, Dansette P, et al. Hepatotoxicity of germander in mice. Gastroenterology. 106:1994;464-472.
39. Lekehal M, Pessayre D, Lereau JM, Moulis C, Fourasté I, Fau D. Hepatotoxicity of the herbal medicine, germander. Metabolic activation of its furano diterpenoids by cytochrome P450 3A depletes cytoskeleton-associated protein thiols and forms plasma membrane blebs in rat hepatocytes. Hepatology. 24:1996;212-218.
40. 2+ plus prooxidants. J Biol Chem. 32:1990;19955-19960.
41. Coles B. Effects of modifying structure on electrophilic reactions with biological nucleophiles. Drug Metab Rev. 15:1984-1985;1307-1334.
42. Pessayre D, Larrey D, Biour M. Drug-induced liver injury. Bircher J, Benhamou JP, McIntyre N, Rizzetto M, Rodés J. Oxford Textbook of Clinical Hepatology, Vol II. 1999;1261-1315 Oxford Universal Press, Oxford.
43. Evan G, Littlewood T. A matter of life and death. Science. 281:1998;1317-1322.
44. Canman CE, Kastan MB. Role of p53 in apoptosis. Adv Pharmacol. 41:1997;429-460.
45. Rossé T, Olivier R, Monney L, Rager M, Conus S, Fellay I, et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature. 391:1998;496-499.
46. Deschamps D, Fisch C, Fromenty B, Berson A, Degott C, Pessayre D. Inhibition by salicylic acid of activation and thus oxidation of long-chain fatty acids. Possible role in the development of Reye's syndrome. J Pharmacol Exp Ther. 259:1991;894-904.
47. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta. 1366:1998;177-196.
48. Botla R, Spivey JR, Bronk SF, Gores GJ. Ursodeoxycholic acid (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J Pharmacol Exp Ther. 272:1995;930-938.
49. Larrey D. Hepatotoxicity of herbal remedies. J Hepatol. 26:(Suppl. 1):1997;47-51.
50. Zamzami N, Susin SA, Marchetti P, Hirsh T, Gomez-Monterrey I, Castedo M, et al. Mitochondrial control of nuclear apoptosis. J Exp Med. 183:1996;1533-1544.
51. 2+ accumulation, and the control of the mitochondrial permeability transition in intact hepatocytes. Mol Cell Biochem. 174:1997;173-179.
52. 2+ pool and induces apoptosis in human hepatoma cells. Cell Biol Int. 17:1993;969-970.
53. Takahachi T, Tanaka M, Inazawa J, Abe T, Suda T, Nagata S. Human Fas ligand: gene structure, chromosomal location and species specificity. Int Immunol. 6:1994;1567-1574.
54. Naumann M, Scheidereit C. Activation of NFκB in vivo is regulated by multiple phosphorylations. EMBO J. 13:1994;4597-4607.
55. Strand S, Hofmann WJ, Grambihler A, Hug H, Volkmann M, Otto G, et al. Hepatic failure and liver cell damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med. 4:1998;588-593.
56. Müller M, Strand S, Hug H, Heninemann EA, Walczak H, Hoffmann WJ, et al. Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest. 99:1997;403-413.
57. Lettéron P, Duchatelle V, Berson A, Fromenty B, Fisch C, Degott C, et al. Increased ethane exhalation, an in vivo index of lipid peroxidation, in alcohol-abusers. Gut. 34:1993;409-414.
58. Mansouri A, Fromenty B, Berson A, Robin MA, Grimbert S, Beaugrand M, et al. Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholics. J Hepatol. 27:1997;96-102.
59. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med. 182:1995;1223-1230.
60. Mansouri A, Gaou I, Fromenty B, Berson A, Lettéron P, Degott C, et al. Premature oxidative aging of mitochondrial DNA in Wilson's disease. Gastroenterology. 113:1997;599-605.
61. Kanofsky JR. Single oxygen production by bleomycin. A comparison with heme-containing compounds. J Biol Chem. 261:1986;13546-13550.
62. Hug H, Strand S, Grambihler A, Galle J, Hack V, Stremmel W, et al. Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. J Biol Chem. 272:1997;28191-28193.
63. Columbano A, Shinozuka H. Liver regeneration versus direct hyperplasia. FASEB J. 10:1996;1118-1128.
64. Roberts RA, Soames AR, Gill JH, James NH, Wheeldom EB. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis. 16:1995;1693-1698.
65. Bayly AC, Roberts RA, Dive C. Suppression of liver cell apoptosis in vitro by the non-genotoxic hepatocarcinogen and peroxisome proliferator nafenopin. J Cell Biol. 125:1994;197-203.
66. Menegazzi M, Carcereri-De Prati A, Suzuki H, Shinozuka H, Pibiri M, Piga R, et al. Liver cell proliferation induced by nafenopin and cyproterone acetate is not associated with increases in activation of transcription factor NF-κB and AP-1 or with expression of tumor necrosis factor α Hepatology. 25:1997;585-592.
67. Plant NJ, Horley NJ, Dickins M, Hasmall S, Elcombe CR, Bell DR. The coordinate regulation of DNA synthesis and suppression of apoptosis is differentially regulated by the liver growth agents, phenobarbital and methylclofanepate. Carcinogenesis. 19:1998;1521-1527.
68. Christensen JG, Gonzales AJ, Cattley RC, Goldsworthy TL. Regulation of apoptosis in mouse hepatocytes and alteration of apoptosis by non-genotoxic carcinogens. Cell Growth Different. 9:1998;815-825.
69. Ray RB, Meyer K, Steele R, Shrivastava A, Aggarwal BB, Ray R. Inhibition of tumor necrosis factor (TNF-α) mediated apoptosis by hepatitis C virus core protein. J Biol Chem. 273:1998;2256-2259.
70. Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 282:1998;490-493.